(19)
(11) EP 4 823 597 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24903141.0

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
C07K 14/705(2006.01)
C12N 15/09(2006.01)
A61P 37/06(2006.01)
A61K 39/395(2006.01)
C07K 19/00(2006.01)
C12N 15/62(2006.01)
A61P 21/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/395; A61P 21/04; A61P 37/06; C07K 14/70571; C07K 2319/30; C07K 2319/02; C07K 2317/52; C07K 2317/526; C07K 2317/71; C07K 16/286; C07K 16/00; A61K 38/00
(86) International application number:
PCT/IL2024/051184
(87) International publication number:
WO 2025/126216 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 US 202363609424 P

(71) Applicant: Canopy Immuno-Therapeutics Ltd.
3087500 Moshav Megadim (IL)

(72) Inventors:
  • OVED, Kfir
    3087500 Moshav Megadim, Hof HaCarmel (IL)
  • DENKBERG, Galit
    3600100 Nofit (IL)
  • REEF, Sharon
    4298401 Tsukei Yam (IL)
  • PINZUR, Yelena
    3446437 Haifa (IL)
  • ARMAN ZELMAN, Inbar
    3680304 Nesher (IL)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)

   


(54) IMPROVED ACETYLCHOLINE RECEPTOR MOLECULES AND USE THEREOF